Global Patients is working with Evidera, a health-outcomes research organization, to conduct research to better understand Neuromyelitis Optica Spectrum Disorder (NMOSD)-related symptoms and impacts most important to patients, as well as evaluate the treatment experiences of patients on various types of treatment for NMOSD. As a participant you will be asked to:

  • Participate in a 60-minute teleconference interview with a researcher from Evidera to describe the symptoms and impacts you experience as a result of NMOSD along with treatment experience
  • Complete two questionnaires about yourself and health status

The study does not involve taking any treatment medication or other medical intervention or trying a medical device.

If you are interested in this study and would like more details, please contact . You will be asked a few additional questions to determine your eligibility. If eligible and interested, we will schedule your interview at a time that’s convenient for you with an available Evidera team member. For your time and participation, you will receive $125 after completing the teleconference interview and $35 for providing proof of NMOSD diagnosis.

Join this Study
Are you already a member of Global Patients?